Literature DB >> 28802875

Primary sclerosing cholangitis - a comprehensive review.

Tom H Karlsen1, Trine Folseraas2, Douglas Thorburn3, Mette Vesterhus4.   

Abstract

Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressive liver disease. Inflammatory bowel disease is usually present and there is a high risk of cholangiocarcinoma and colorectal cancer. Most patients ultimately require liver transplantation, after which disease recurrence may occur. With limited therapeutic options and a lack of proven surveillance strategies, patients currently have significant unmet needs. In the present seminar, we provide a comprehensive review of the status of the field. We emphasise developments related to patient stratification and disease behaviour, and provide an overview of management options from a practical, patient-centered perspective. We survey advances made in the understanding of PSC pathogenesis and summarise the ongoing efforts to develop an effective therapy based on these insights.
Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; IgG4-associated cholangitis; Primary sclerosing cholangitis

Mesh:

Year:  2017        PMID: 28802875     DOI: 10.1016/j.jhep.2017.07.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  131 in total

1.  Knockout of the Tachykinin Receptor 1 in the Mdr2-/- (Abcb4-/-) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.

Authors:  Ludovica Ceci; Heather Francis; Tianhao Zhou; Thao Giang; Zhihong Yang; Fanyin Meng; Nan Wu; Lindsey Kennedy; Konstantina Kyritsi; Vik Meadows; Chaodong Wu; Suthat Liangpunsakul; Antonio Franchitto; Amelia Sybenga; Burcin Ekser; Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2020-07-23       Impact factor: 4.307

Review 2.  The Contribution of B Cells in Autoimmune Liver Diseases.

Authors:  Sarah A Taylor; David N Assis; Cara L Mack
Journal:  Semin Liver Dis       Date:  2019-06-21       Impact factor: 6.115

Review 3.  Update in the Care and Management of Patients with Primary Sclerosing Cholangitis.

Authors:  Mai Sedki; Cynthia Levy
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

4.  Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione.

Authors:  Halyna Kuznietsova; Iryna Byelinska; Natalia Dziubenko; Oksana Lynchak; Demyd Milokhov; Olga Khilya; Nataliya Finiuk; Olga Klyuchivska; Rostyslav Stoika; Volodymyr Rybalchenko
Journal:  Mol Cell Biochem       Date:  2021-04-01       Impact factor: 3.396

Review 5.  Undiagnosed liver diseases.

Authors:  Emily Gao; Julian Hercun; Theo Heller; Sílvia Vilarinho
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 6.  Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.

Authors:  Bettina M Buchholz; Panagis M Lykoudis; Reena Ravikumar; Joerg M Pollok; Giuseppe K Fusai
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

7.  GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump.

Authors:  Georg Schneditz; Joshua E Elias; Ester Pagano; M Zaeem Cader; Svetlana Saveljeva; Kathleen Long; Subhankar Mukhopadhyay; Maryam Arasteh; Trevor D Lawley; Gordon Dougan; Andrew Bassett; Tom H Karlsen; Arthur Kaser; Nicole C Kaneider
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

Review 8.  The IBD and PSC Phenotypes of PSC-IBD.

Authors:  Amanda Ricciuto; Binita M Kamath; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

Review 9.  [Primary sclerosing cholangitis : Current diagnostics and treatment].

Authors:  T Liwinski; C Schramm
Journal:  Internist (Berl)       Date:  2018-06       Impact factor: 0.743

Review 10.  Sex-related factors in autoimmune liver diseases.

Authors:  Dorothee Schwinge; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.